Every article, report, and earnings note where PM appears.
Philip Morris International Inc. (PM) rises after a strong Q2 earnings beat and fresh optimism around ZYN, IQOS, and VEEV. The stock moved above its listed 52-week high as investors reprice PMI’s smoke-free growth story, though trading volume has not confirmed a broad breakout.
Philip Morris International is evolving from a cigarette cash cow into a smoke-free growth story, with reduced-risk products now approaching half of revenue. Strong execution in IQOS and other nicotine alternatives supports the Buy case, though leverage and valuation keep upside measured.
PepsiCo's post-earnings drop looks like a market fixated on one weak region while ignoring the part of the quarter that kept the broader story alive. International organic revenue growth, improving global volume, and unchanged full-year guidance matter more than a soft North America print.
Philip Morris International Inc. (PM) rises sharply as investors continue to reward strong Q1 results and FDA reauthorization for IQOS. The move highlights growing confidence in the company’s smoke-free transition, steady earnings execution, and durable dividend appeal.
Philip Morris International Inc. (PM) rises after a strong earnings report beat revenue and profit expectations, outweighing a small full-year guidance trim. Investors focused on steady execution, pricing power, and continued smoke-free growth, even as Zyn shipments fell and regulatory uncertainty lingered.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate PM ReportCancel anytime